Electromed (NYSE:ELMD) Issues Quarterly Earnings Results

Electromed (NYSE:ELMD - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13, Zacks reports. The firm had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Stock Up 0.3 %

Electromed stock traded up $0.08 during mid-day trading on Friday, hitting $28.97. The company's stock had a trading volume of 120,768 shares, compared to its average volume of 41,874. The stock has a market capitalization of $245.09 million, a P/E ratio of 40.24 and a beta of 0.27. Electromed has a twelve month low of $9.81 and a twelve month high of $30.00. The stock's fifty day moving average price is $22.14 and its two-hundred day moving average price is $17.82.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.